Embody

A compounded GLP-1 programme sold as an e-commerce storefront rather than as a clinic: medication is added to a cart and paid for first, and an OpenLoop Health clinician then decides whether the buyer qualifies. It sells supplies of up to twelve months in a single purchase, at a twelve-month rate well below its own one-month price.

At a glance

Access model

Compounded only

Medications offered

Compounded semaglutide (injectable)Compounded tirzepatide (injectable)

Prescriber

Clinicians of OpenLoop Health, described in Embody's own consent page as meeting the buyer after checkout to determine whether they qualify

Insurance

Cash-pay model; not built around insurance billing

Membership / program fee

No separate membership fee published — the advertised price is the medication programme itself, billed as a recurring subscription that must be cancelled at least 72 hours before the next billing date

Cash-pay from

Compounded semaglutide advertised at $79 for a first month against a $299 regular price, and $828 for a twelve-month supply; compounded tirzepatide at $129 against $349. The one-month products are presented on the product page as a one-time purchase while the terms describe an automatically recurring subscription

States served

Not published — the terms say the service is available to people located in certain states without naming them

On compounding

Built entirely around compounded medication, and unusually direct about it: Embody's own safety page states that compounded GLP-1s "are not FDA-approved or evaluated for safety, efficacy, or quality" and names its partner pharmacies. Compounded drugs are not FDA-approved products in their own right; the FDA does not review compounded formulations for safety, effectiveness, or manufacturing quality the way it does an approved drug.

For the fuller regulatory picture — the pending FDA proposal on 503B compounding and what it does and doesn’t affect — see the compounding explainer that sits above every provider we list, Embody included.

Questions people ask before signing up

Every answer below states only what Embody publishes about itself, read on 2026-09-27, plus what is on the public record. We have not used this service and we do not rate it.

Who writes the prescription at Embody?

Clinicians of OpenLoop Health, described in Embody's own consent page as meeting the buyer after checkout to determine whether they qualify. Every GLP-1 receptor agonist is prescription-only in the United States, so a service that supplies one without an assessment is not operating lawfully, whatever it calls itself. This is Embody's own published description of who evaluates you, read on 2026-09-27.

Does Embody use compounded medication?

Yes. Its published offer includes Compounded semaglutide (injectable), Compounded tirzepatide (injectable). A compounded preparation is not a generic and has not been reviewed by the FDA for identity, purity or sterility — that is the difference the price reflects, and it is the reason a compounded price is lower.

What does Embody actually cost per month?

No separate membership fee published — the advertised price is the medication programme itself, billed as a recurring subscription that must be cancelled at least 72 hours before the next billing date Compounded semaglutide advertised at $79 for a first month against a $299 regular price, and $828 for a twelve-month supply; compounded tirzepatide at $129 against $349. The one-month products are presented on the product page as a one-time purchase while the terms describe an automatically recurring subscription We do not derive a monthly total where a provider does not publish enough to build one.

Does Embody take insurance?

Cash-pay model; not built around insurance billing. Whether your own plan covers a GLP-1 at all is a separate question from whether a provider will bill it, and it is usually the one that decides the price — many employer plans exclude weight-management medications as a category.

Is Embody available in my state?

Not published — the terms say the service is available to people located in certain states without naming them. Where a provider does not publish a state list we say so rather than assume nationwide coverage, and this field is read from Embody's own site on 2026-09-27.

Has Embody been subject to litigation or regulatory action?

Payment is taken before the clinical evaluation. Embody's medical consent page states that "an OpenLoop Health clinician will meet with an individual after checkout to determine if they qualify", and its refund policy states that "ALL PAYMENTS FOR THE SUBSCRIPTION SERVICES ARE FINAL AND NON-REFUNDABLE AT TIME OF PURCHASE", with multi-month plans "NON-REFUNDABLE IN WHOLE AND IN PART". A refund is offered where a clinician finds the buyer medically ineligible, less "the value of services already rendered" — so the money is returnable if Embody declines you, but not if you qualify and change your mind. The same storefront sells sermorelin, NAD+, glutathione and MIC-B12 injectables alongside the GLP-1 products, each with its own intake page. None of those is an approved obesity treatment, and their presence beside a weight-loss programme is worth knowing before signing up. We record what is on the public record with a source, and we do not characterise it. An allegation is an allegation until a court says otherwise, and where a case has been dismissed we say that too.

How to reach Embody

Visit Embody’s own site to confirm current pricing, state availability, and eligibility — all of the figures above can change without notice, and only the provider itself has the current version.

Disclosure We earn nothing from this link. We hold no referral, affiliate, or advertising arrangement with this provider, and this listing was compiled from their own published terms. How we’re funded.

How this compares

Other providers with a similar access model or worth contrasting against:

This page is general education, not medical advice. Talk to your own healthcare provider about your situation before starting, stopping, or changing any medication.